Clinical Trial Update: Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes [Phase 2]

View source ↗

Summary

This clinical trial update discusses a Phase 2 study evaluating allogeneic islet transplantation for Type 1 diabetes. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Patients With Type 1 Diabetes | Phase 2 | Status: UNKNOWN